Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current DebtNotes PayablesOther Non-Current LiabilitiesPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Stellus Capital Investment (SCM) Cash & Equivalents (2021 - 2025)

Stellus Capital Investment (SCM) has disclosed Cash & Equivalents for 5 consecutive years, with $25.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Cash & Equivalents rose 24.79% to $25.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $25.0 million, a 24.79% increase, with the full-year FY2025 number at $25.0 million, up 24.79% from a year prior.
  • Cash & Equivalents was $25.0 million for Q4 2025 at Stellus Capital Investment, up from $9.0 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $48.4 million in Q1 2024 to a low of $9.0 million in Q3 2025.
  • A 5-year average of $27.3 million and a median of $25.0 million in 2025 define the central range for Cash & Equivalents.
  • Peak YoY movement for Cash & Equivalents: skyrocketed 171.2% in 2024, then plummeted 77.51% in 2025.
  • Stellus Capital Investment's Cash & Equivalents stood at $44.2 million in 2021, then grew by 8.76% to $48.0 million in 2022, then plummeted by 45.62% to $26.1 million in 2023, then decreased by 23.22% to $20.1 million in 2024, then rose by 24.79% to $25.0 million in 2025.
  • Per Business Quant, the three most recent readings for SCM's Cash & Equivalents are $25.0 million (Q4 2025), $9.0 million (Q3 2025), and $40.0 million (Q2 2025).